Document is current
Any future updates will be listed below
-
Authors
Shadrin, Alexey A.
Hindley, Guy
Hagen, Espen
Parker, Nadine
Tesfaye, Markos
Jaholkowski, Piotr
Rahman, Zillur
Kutrolli, Gleda
Fominykh, Vera
Djurovic, Srdjan
Smeland, Olav B.
O’Connell, Kevin S.
van der Meer, Dennis
Frei, Oleksandr
Andreassen, Ole A.
Dale, Anders M.
-
Funding
Funding for this research was provided by:
European Union’s Horizon 2020 Research and Innovation Programme (801133, 964874)
Norges Forskningsråd (334920, 326813)
National Institutes of Health (5R01MH124839-02, R01MH123724-01)
The European Economic Area and Norway Grants (EEA-RO-NO-2018-0573)
KG Jebsen Stiftelsen, The South-East Norway Regional Health Authority (2022-087)
Helse Sør-Øst RHF (2022073)
University of Oslo
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 8 August 2025
First Online: 29 September 2025
Declarations
:
: The UK Biobank is advised by its Ethics Advisory Committee (EAC) and consent to take part in UK Biobank has been obtained from the participants. This study has been conducted using the UK Biobank Resource under accession number 27412. The research was performed in accordance with the principles of the Helsinki Declaration.
: Not applicable.
: Srdjan Djurovic has received speaker’s Honoria from Lundbeck. Anders M. Dale is a Founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is also a member of the Scientific Advisory Board of Human Longevity, Inc. (HLI), and the Mohn Medical Imaging and Visualization Centre in Bergen, Norway. He receives funding through a research agreement with General Electric Healthcare (GEHC). The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. Ole A. Andreassen has received speaker fees from Lundbeck, Janssen, Otsuka, and Sunovion and is a consultant to Cortechs.ai and Precision Health AS. All remaining authors declare that they have no competing interests.
